BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
BeyondSpring Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.51−0.05 (-8.28%)
Close on Oct 19, 2026
- Market cap
- $21.09M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.2571 (−71.02%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
BeyondSpring Inc. reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$16.75M.
Revenue
$0
TTM Q2 2026
Operating income
-$8.35M
TTM Q2 2026
Free cash flow
-$16.75M
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $21.09M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -79.40%
Fundamentals
- Revenue
- $0
- Net income
- -$6.69M
- Free cash flow
- -$16.75M
- Book value per share
- -$0.86
- Diluted shares
- 41M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
$0
Operating income
-$8.35M
Net income
-$6.69M
EPS, diluted
–
Free cash flow
-$16.75M
Reported periodTrailing twelve months